Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

piR-39980 mediates doxorubicin resistance in fibrosarcoma by regulating drug accumulation and DNA repair
Basudeb Das, Neha Jain, Bibekanand Mallick
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Targeting epigenetic regulators to overcome drug resistance in cancers
Nan Wang, Ting Ma, Bin Yu
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 141
Current Molecular Combination Therapies Used for the Treatment of Breast Cancer
Yiling Wang, Audrey Minden
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11046-11046
Open Access | Times Cited: 61
Ribonucleotide reductase M2 (RRM2): Regulation, function and targeting strategy in human cancer
Zanwen Zuo, Zerong Zhou, Yuzhou Chang, et al.
Genes & Diseases (2022) Vol. 11, Iss. 1, pp. 218-233
Open Access | Times Cited: 45
Doxorubicin-loaded micelles in tumor cell-specific chemotherapy
Yasir Qasim Almajidi, Mustafa M. Kadhim, Fahad Alsaikhan, et al.
Environmental Research (2023) Vol. 227, pp. 115722-115722
Closed Access | Times Cited: 32
The burgeoning importance of PIWI-interacting RNAs in cancer progression
Xinpei Deng, Tianle Liao, Jindong Xie, et al.
Science China Life Sciences (2023) Vol. 67, Iss. 4, pp. 653-662
Closed Access | Times Cited: 14
Novel roles of PIWI proteins and PIWI-interacting RNAs in human health and diseases
Zeyu Wu, Xiao Yu, Shuijun Zhang, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 13
Recombinant Methioninase Is Selectively Synergistic With Doxorubicin Against Wild-type Fibrosarcoma Cells Compared to Normal Cells and Overcomes Highly-Doxorubicin-resistant Fibrosarcoma
Sei Morinaga, Qinghong Han, KOHEI MIZUTA, et al.
Anticancer Research (2024) Vol. 44, Iss. 8, pp. 3261-3268
Closed Access | Times Cited: 4
Stimulator of Interferon Genes-Activated Biomimetic Dendritic Cell Nanovaccine as a Chemotherapeutic Booster to Enhance Systemic Fibrosarcoma Treatment
Zhao Wang, Fenglin Miao, Lingwei Gu, et al.
ACS Nano (2024) Vol. 18, Iss. 35, pp. 24219-24235
Closed Access | Times Cited: 4
HIWI2 induces G2/M cell cycle arrest and apoptosis in human fibrosarcoma via the ROS/DNA damage/p53 axis
Basudeb Das, Swapnil Sahoo, Bibekanand Mallick
Life Sciences (2022) Vol. 293, pp. 120353-120353
Closed Access | Times Cited: 18
Critical appraisal of the piRNA-PIWI axis in cancer and cancer stem cells
Elena Garcia‐Borja, František Siegl, Rosana Mateu, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 3
FDFT1 repression by piR-39980 prevents oncogenesis by regulating proliferation and apoptosis through hypoxia in tongue squamous cell carcinoma
Trisha Chattopadhyay, Bibekanand Mallick
Life Sciences (2023) Vol. 329, pp. 121954-121954
Closed Access | Times Cited: 9
Comparative effects of free doxorubicin, liposome encapsulated doxorubicin and liposome co-encapsulated alendronate and doxorubicin (PLAD) on the tumor immunologic milieu in a mouse fibrosarcoma model
Md. Rakibul Islam, Jalpa Patel, Patrícia Inês Back, et al.
Nanotheranostics (2022) Vol. 6, Iss. 4, pp. 451-464
Open Access | Times Cited: 14
Correlating tissue and plasma‑specific piRNA changes to predict their possible role in pancreatic malignancy and chronic inflammation
Barsha Saha, Shouvik Chakravarty, Sukanta Ray, et al.
Biomedical Reports (2024) Vol. 21, Iss. 6
Open Access | Times Cited: 2
miR-128-3p suppresses tumor growth and enhances chemosensitivity in tongue squamous cell carcinoma through MAP2K7 targeting
Pooja Gupta, Bibekanand Mallick
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 2
In Silico Study of piRNA Interactions with the SARS-CoV-2 Genome
Aigul Akimniyazova, O. Yu. Yurikova, Anna Pyrkova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9919-9919
Open Access | Times Cited: 13
Impact of Non-Coding RNAs on Chemotherapeutic Resistance in Oral Cancer
Karen Yamaguchi, Tomofumi Yamamoto, Junichiro Chikuda, et al.
Biomolecules (2022) Vol. 12, Iss. 2, pp. 284-284
Open Access | Times Cited: 12
miR‐203a—A multifaceted regulator modulating cancer hallmarks and therapy response
Priyajit Biswal, Anthony Lalruatfela, Subham Kumar Behera, et al.
IUBMB Life (2023) Vol. 76, Iss. 3, pp. 108-124
Closed Access | Times Cited: 7
Genome-wide profiling of dysregulated piRNAs and their target genes implicated in oncogenicity of tongue squamous cell carcinoma
Trisha Chattopadhyay, Pooja Gupta, Rojalin Nayak, et al.
Gene (2022) Vol. 849, pp. 146919-146919
Closed Access | Times Cited: 11
A Cluster of Metabolic-Related Genes Serve as Potential Prognostic Biomarkers for Renal Cell Carcinoma
Shuo Huang, Qihan Luo, Junhao Huang, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 9
Non‐coding RNAs and their potential exploitation in cancer therapy‐related cardiotoxicity
Riccardo Bernasconi, Gabriela M. Kuster
British Journal of Pharmacology (2024) Vol. 182, Iss. 2, pp. 296-315
Open Access | Times Cited: 1
miR-185-5p rewires cisplatin resistance by restoring miR- 203a-3p expression via downregulation of SOX9
Priyajit Biswal, Bibekanand Mallick
DNA repair (2024) Vol. 142, pp. 103750-103750
Closed Access | Times Cited: 1
DNA damage response-related ncRNAs as regulators of therapy resistance in cancer
Ziru Gao, Xinchi Luan, Xuezhe Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
TarpiD, a database of putative and validated targets of piRNAs
Pooja Gupta, Gourab Das, Trisha Chattopadhyay, et al.
Molecular Omics (2023) Vol. 19, Iss. 9, pp. 706-713
Closed Access | Times Cited: 2
Establishment and characterization of 18 Sarcoma Cell Lines: Unraveling the Molecular Mechanisms of Doxorubicin Resistance in Sarcoma Cell Lines
Yong Eun Cho, Soon‐Chan Kim, Ha Jeong Kim, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access
Construction of a nomogram model for predicting peritoneal metastasis in gastric cancer based on ferroptosis-relate genes and clinicopathological features
Xiaotong Sun, Kaipeng Duan, Xiaochun Shen, et al.
Research Square (Research Square) (2024)
Open Access
Page 1 - Next Page

Scroll to top